Evidence exists for metformin use in treatment of both tuberculosis and rheumatological diseases, suggesting that metformin may even be a safer alternative to TNF inhibitors (Gharib et al., 2021; Kim et al., 2022). This evidence concerns the gene TNF and tuberculosis.